The Drug Pipeline

The US Generic Drug Market

The largest alleged price-fixing cartel in US history

Patent thickets, delayed biosimilars and PBM private labels

Blockbuster obesity and diabetes drugs at the centre of fights over price, compounding and safety

A century-old drug, lockstep price increases and the PBM rebate system on trial

Pfizer's incumbency, new rivals and accusations of unfair competition